117 results for «100»

Filter By

117 results

Vascular robotics: Robocath unveils survey findings on users’ current expectations and future developments

15 May 2024

Successful Stent-less Percutaneous Coronary Intervention of Chronic Total Occlusion by Ablation Devices in a Young Adult

04 Nov 2021

View this case with a 38-year-old male with effort angina and chronic total occlusion at the ostial segment of the left anterior descending artery.

Successful Stent-less Percutaneous Coronary Intervention of Chronic Total Occlusion by Ablation Devices in a Young Adult

BIOTRONIK Sets New Clinical Benchmark with Ultrathin Strut Orsiro Coronary Drug-Eluting Stent

28 Feb 2022

BIOTRONIK's New Absorbable Magnesium Scaffold Achieves Major Milestone in BIOMAG-I Clinical Trial

01 Mar 2022

LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started

29 Jul 2022

TRISCEND: six-month outcomes of transfemoral tricuspid valve replacement in patients with TR - a written review

09 Nov 2021

 

The 6-month follow-up of the TRISCEND study was presented during the TCT Congress 2021 by principal investigator Susheel Kodali. Alessandro Sticchi & Jonathan Curio offer a review of this trial.

Alessandro Sticchi

Author

Alessandro Sticchi
Jonathan Curio

Author

Jonathan Curio
TRISCEND Study: six-month outcomes of transfemoral tricuspid valve replacement in patients with tricuspid regurgitation

Robocath concludes first European clinical study to demonstrate safety and efficacy of robotic coronary angioplasty performed with R-One

12 Jan 2022

DAPT-SHOCK-AMI trial: Cangrelor in cardiogenic shock

03 Sep 2025

Kalaivani Mahadevan and Fizzah Choudry provide their take on DAPT-SHOCK-MI presented by Zuzana Motovska at ESC Congress 2025 in Madrid.

Fizzah Choudry

Author

Fizzah Choudry
Kalaivani Mahadevan

Author

Kalaivani Mahadevan
DAPT-SHOCK-AMI trial: Cangrelor in cardiogenic shock

The top ten impactful papers from 2025 on tricuspid intervention we almost missed

13 Jan 2026

Transcatheter interventions have rapidly reshaped the management of tricuspid valve disease, with landmark trials establishing feasibility and early clinical benefit.

Beyond these pivotal studies, a series of less visible but highly informative papers addressed mechanisms, complications, patient phenotypes, and unintended consequences of intervention.

This curated selection highlights ten impactful tricuspid...

Alessandro Sticchi

Author

Alessandro Sticchi
The top ten impactful papers on tricuspid intervention we almost missed

Cardiac Dimensions raises $35 Million in Series D financing

05 Jan 2023

World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!

29 Sep 2023

Global burden of Cardiovascular Disease

Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...

Vijay Kunadian

Author

Vijay Kunadian
World Heart Day 2023

Landmark New England Journal of Medicine publication reports positive results from PROMISE II pivotal trial showing that LimFlow system saves most patients with end-stage peripheral artery disease from major amputation

30 Mar 2023

Positive echocardiography data from BioCardia phase III CardiAMP cell therapy heart failure trial presented at American College of Cardiology annual meeting

06 Mar 2023

GLORIOUS - Efficacy of restrictive versus liberal oxygenation or Exenatide in patients undergoing coronary artery bypass grafting or aortic valve replacement – a randomised clinical trial

21 Nov 2024

Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.

Edoardo Zancanaro

Author

Edoardo Zancanaro
GLORIOUS

Effective techniques for performing DCB angioplasty

16 Jan 2025

Drug-coated balloon (DCB) angioplasty has become a valuable alternative to drug-eluting stents in treating coronary artery disease. To achieve optimal outcomes, proper lesion preparation and techniques to minimise drug loss are crucial.

This article highlights key steps and best practices for performing DCB angioplasty, ensuring effective drug delivery and...

Valeria Paradies

Author

Valeria Paradies

Author

Gianluca Mincione
Effective techniques for performing DCB angioplasty

EuroPCR 2024 – Built by and for its participants, more than ever before

29 Mar 2024

Over 11,000 participants from around the globe are once again expected at EuroPCR – a Course tailored for interventional cardiologists, cardiac surgeons, imaging specialists, radiologists, nurses, allied professionals and other practitioners, as well as researchers, innovators and industry representatives. They will be sharing their knowledge, skills and experience on...

EuroPCR 2024 – Built by and for its participants, more than ever before

A large-scale, randomized trial of orbital atherectomy vs. conventional balloon angioplasty in severely calcified coronary arteries prior to DES implantation (ECLIPSE)

30 Oct 2024

Nicola Ryan provides her take on the ECLIPSE trial presented by Ajay J. Kirtane at TCT 2024 in Washington.

Nicola Ryan

Author

Nicola Ryan
A large-scale, randomized trial of orbital atherectomy vs. conventional balloon angioplasty in severely calcified coronary arteries prior to DES implantation (ECLIPSE)

The RELIEVE-HF study: is an atrial septal shunt beneficial in HFrEF?

07 Apr 2024

Charles Fauvel provides his take on the RELIEVE-HF study outcomes presented by Gregg W. Stone at ACC.24 in Atlanta.

Charles Fauvel

Author

Charles Fauvel
The RELIEVE-HF study: is an atrial septal shunt beneficial in HFrEF?

First-in-human data for Sensome clot-sensing guidewire used in ischemic stroke treatment demonstrate ability to automate clot characterization with no safety issues

05 Jun 2024

Real-world outcomes with the PASCAL Platform in TR

03 Dec 2021

The PASCAL platform, comprising the PASCAL and PASCAL Ace implants, received its CE mark for TR in May 2020 and has been shown to be an effective and safe treatment option for patients with TR.3,4,6 Professor Jörg Hausleiter and Dr Mirjam Wild now describe their single-centre experience...

Real-world outcomes with the PASCAL Platform in TR
Didn’t find what you were looking for?